glucose, (beta-d)-isomer has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y; He, Y; Hu, Z; Lv, Z; Meng, X; Mou, X; Pan, Y; Zhao, X | 1 |
| Berretta, M; Bonelli, A; Botti, G; Caronna, A; Cocco, S; Conforti, G; De Laurentiis, M; Lombari, MC; Maurea, N; Quagliariello, V; Rea, G | 1 |
| Azzimonti, B; Cochis, A; Dziedzic, A; Iriti, M; Kabała-Dzik, A; Kubina, R; Rimondini, L; Sorrentino, R; Varoni, EM; Wojtyczka, RD | 1 |
| Joung, YH; Kang, DY; Kim, DH; Lee, HG; Park, YM; Sp, N; Yang, YM | 1 |
| Grossert, A; Kempa, A; Nolte, J; Pöttgen, LA; Schörken, U; Sperlich, J; Teusch, N | 1 |
| Abd El-Hafeez, AA; Abdelhamid, MAA; Fujimura, T; Ghosh, P; Hosoi, T; Ibrahim, ARN; Kawamoto, S; Khalifa, HO; Mahdy, EAM; Montano, MM; Ozawa, K; Pack, SP; Sharma, V; Shouman, SA | 1 |
| Han, T; He, J; Liang, L; Liu, J; Liu, X; Shao, Y; Wang, Z; Wu, P; Xia, L | 1 |
| Cheng, F; Eng, C; Fang, J; Hou, Y; Huang, Y; Jiang, X; Lathia, J; Lu, W; Nussinov, R; Reizes, O; Wang, Q; Wang, Z | 1 |
| Guo, S; Guo, YD; Li, H; Li, X; Liu, M; Ma, W; Tsang, SY; Wang, L; Wang, Z; Yang, S; Zhan, J; Zhang, H; Zhang, Z | 1 |
9 other study(ies) available for glucose, (beta-d)-isomer and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Engineered Red Blood Cell Membrane-Coating Salidroside/Indocyanine Green Nanovesicles for High-Efficiency Hypoxic Targeting Phototherapy of Triple-Negative Breast Cancer.
Topics: Cell Line, Tumor; Erythrocyte Membrane; Glucosides; Humans; Hypoxia; Indocyanine Green; Nanoparticles; Phenols; Photochemotherapy; Phototherapy; Triple Negative Breast Neoplasms | 2022 |
NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells.
Topics: Antineoplastic Agents, Immunological; Benzhydryl Compounds; Biomarkers, Pharmacological; Cardiotoxicity; Cell Line, Tumor; CTLA-4 Antigen; Female; Glucose; Glucosides; Humans; Hyperglycemia; Ipilimumab; Leukotriene B4; Myeloid Differentiation Factor 88; Myocytes, Cardiac; NLR Family, Pyrin Domain-Containing 3 Protein; Sodium-Glucose Transporter 2 Inhibitors; Transcription Factor RelA; Triple Negative Breast Neoplasms | 2020 |
Rutin, a Quercetin Glycoside, Restores Chemosensitivity in Human Breast Cancer Cells.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Cycle Checkpoints; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flavonoids; Glucosides; Glycosides; Humans; Neoplasm Proteins; Quercetin; Rutin; Triple Negative Breast Neoplasms | 2017 |
Salidroside inhibits migration, invasion and angiogenesis of MDA‑MB 231 TNBC cells by regulating EGFR/Jak2/STAT3 signaling via MMP2.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Movement; Cell Survival; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Janus Kinase 2; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Phenols; Signal Transduction; STAT3 Transcription Factor; Triple Negative Breast Neoplasms | 2018 |
Glucansucrase catalyzed synthesis and functional characterization of nordihydroguaiaretic acid glucosides.
Topics: Antioxidants; Cell Movement; Female; Glucosides; Glycosyltransferases; Humans; Iridoid Glucosides; Larrea; Masoprocol; Triple Negative Breast Neoplasms; Tumor Cells, Cultured | 2019 |
Anticancer effect of nor-wogonin (5, 7, 8-trihydroxyflavone) on human triple-negative breast cancer cells via downregulation of TAK1, NF-κB, and STAT3.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Female; Flavanones; Flavones; Glucosides; Humans; MAP Kinase Kinase Kinases; NF-kappa B; STAT3 Transcription Factor; Triple Negative Breast Neoplasms | 2019 |
Cyanidin-3-glucoside induces mesenchymal to epithelial transition via activating Sirt1 expression in triple negative breast cancer cells.
Topics: Anthocyanins; Antigens, CD; Cadherins; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Female; Glucosides; Humans; MicroRNAs; NF-kappa B; Signal Transduction; Sirtuin 1; Snail Family Transcription Factors; Triple Negative Breast Neoplasms; Vimentin; Zonula Occludens-1 Protein | 2019 |
A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Biological Products; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Flavanones; Glucosides; Hedgehog Proteins; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Scutellaria baicalensis; Signal Transduction; Triple Negative Breast Neoplasms | 2019 |
Cyanidin-3-o-glucoside directly binds to ERα36 and inhibits EGFR-positive triple-negative breast cancer.
Topics: Animals; Anthocyanins; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; ErbB Receptors; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Glucosides; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Microcirculation; Mitochondria; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Protein Binding; Proto-Oncogene Proteins c-akt; Superoxide Dismutase; Triple Negative Breast Neoplasms | 2016 |